Open AccessMR‐proADM as a Prognostic Marker in Patients With ST ‐Segment–Elevation Myocardial Infarction—DANAMI‐3 (a Danish Study of Optimal Acute Treatment of Patients With STEMI ) Substudy
Author(s) -
Falkentoft Alexander C.,
Rørth Rasmus,
Iversen Kasper,
Høfsten Dan E.,
Kelbæk Henning,
Holmvang Lene,
Frydland Martin,
Schoos Mikkel M.,
Helqvist Steffen,
Axelsson Anna,
Clemmensen Peter,
Jørgensen Erik,
Saunamäki Kari,
Tilsted HansHenrik,
Pedersen Frants,
TorpPedersen Christian,
Kofoed Klaus F.,
Goetze Jens P.,
Engstrøm Thomas,
Køber Lars
Publication year - 2018
Publication title -
journal of the american heart association
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.494
H-Index - 85
ISSN - 2047-9980
DOI - 10.1161/jaha.117.008123
Subject(s) - medicine , hazard ratio , myocardial infarction , confidence interval , cardiology , heart failure , proportional hazards model , st segment , receiver operating characteristic , area under the curve , percentile , statistics , mathematics
Midregional proadrenomedullin (MR-proADM) has demonstrated prognostic potential after myocardial infarction (MI). Yet, the prognostic value of MR-proADM at admission has not been examined in patients with ST-segment-elevation MI (STEMI).